NCT00605930View on ClinicalTrials.gov

A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Progressive Supranuclear Palsy
Interventions
DIETARY_SUPPLEMENT

Pyruvate, creatine, niacinamide

A bar of 2 gm of pyruvate and 1 gm of creatine, and a pill of 1 gm of niacinamide once a day for 24 weeks.

DIETARY_SUPPLEMENT

Placebo

25% of subjects will receive a placebo bar and a placebo pill once a day for 24 weeks.

Trial Locations (1)

40202

Frazier Rehab, Louisville

All Listed Sponsors
lead

University of Louisville

OTHER

NCT00605930 - A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy. | Biotech Hunter | Biotech Hunter